Tamasauskiene Laura, Gradauskiene Brigita
Department of Immunology and Allergology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Laboratory of Immunology, Department of Immunology and Allergology, Lithuanian University of Health Sciences, Lithuanian University of Health Sciences, Eiveniu str. 2, Kaunas, Lithuania.
J Inflamm (Lond). 2024 Oct 31;21(1):41. doi: 10.1186/s12950-024-00415-9.
T lymphocyte helper (Th) 2 plays the main role in pathogenesis of allergic airway diseases (AAD). Recent studies showed that interleukin (IL) 33, Th17 and Th22 also may be involved in allergic inflammation. The aim is to evaluate cytokine level before and after nasal challenge with Dermatophagoides pteronyssinus in patients with AAD.
Patients with persistent allergic rhinitis (AR) with or without allergic asthma (AA) allergic to house dust mite and healthy individuals underwent nasal challenge with Dermatophagoides pteronyssinus. Measurements of IL-13, IL-17, IL-22 and IL-33 in serum and nasal lavage were performed before, 2 and 22 h after nasal challenge by ELISA.
. Ten patients with AR only, 6 patients with AR and AA and 7 healthy individuals were involved in the study. Serum IL-22 level significantly increased in patients with AR and AA and nasal lavage IL-22 tended to increase in patients with AAD after nasal challenge. Serum IL-13 level tended to increase in patients with AR and AA. IL-13 level in nasal lavage fluid decreased at 22 h after nasal challenge in patients with AR only. IL-17 level in serum and nasal lavage decreased in patients with AAD. Serum IL-33 tended to increase after nasal challenge whereas IL-33 in nasal lavage significantly decreased.
Cytokine profile differs between local and systemic compartments and between patients with allergic rhinitis only and patients with allergic rhinitis and asthma after nasal challenge.
辅助性T淋巴细胞2(Th2)在变应性气道疾病(AAD)的发病机制中起主要作用。最近的研究表明,白细胞介素(IL)-33、Th17和Th22也可能参与变应性炎症。目的是评估AAD患者在接受尘螨变应原鼻腔激发前后的细胞因子水平。
对尘螨过敏的持续性变应性鼻炎(AR)患者(伴或不伴有变应性哮喘(AA))以及健康个体进行尘螨变应原鼻腔激发。在鼻腔激发前、激发后2小时和22小时,通过酶联免疫吸附测定法(ELISA)检测血清和鼻腔灌洗液中IL-13、IL-17、IL-22和IL-33的水平。
10例单纯AR患者、6例AR合并AA患者和7名健康个体参与了本研究。鼻腔激发后,AR合并AA患者血清IL-22水平显著升高,AAD患者鼻腔灌洗液中IL-22有升高趋势。AR合并AA患者血清IL-13水平有升高趋势。单纯AR患者鼻腔激发后22小时,鼻腔灌洗液中IL-13水平降低。AAD患者血清和鼻腔灌洗液中IL-17水平降低。鼻腔激发后血清IL-33有升高趋势,而鼻腔灌洗液中IL-33显著降低。
鼻腔激发后,局部和全身各腔室之间以及单纯变应性鼻炎患者与变应性鼻炎合并哮喘患者之间的细胞因子谱不同。